A light-emitting titanium catalyst could serve as a cheaper and safer alternative to commonly used toxic metals, such as ruthenium and iridium, during the production of antiviral medicines.

False
Using green light a catalyst could help scientist conduct safe and cheap reactions
A light-emitting titanium catalyst could serve as a cheaper and safer alternative to commonly used toxic metals, such as ruthenium and iridium, during the production of antiviral medicines.
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
False
False
February 3, 2025
4 min read
With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?
December 1, 2014
2 min read
Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?
April 2, 2025
2 min read
How fluid flow through the body can affect the ways in which antibiotics work.
April 7, 2025
4 min read
Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.
False